Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.455
+0.075 (5.43%)
Aug 21, 2026, 10:34 AM EDT - Market open
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $5.85 million as of August 21, 2026. Its market cap has increased by 58.72% in one year.
Market Cap
5.85M
Enterprise Value
1.44M
1-Year Change
58.72%
Ranking
Category
Stock Price
$1.46
ChartMarket Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $5.85M, a decrease of -89.82%. That is a compound annual growth rate of -36.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 5.85M | -5.17% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Addex Therapeutics | 6.18M |
| Bolt Biotherapeutics | 6.16M |
| Ensysce Biosciences | 6.13M |
| CollPlant Biotechnologies | 6.01M |
| Processa Pharmaceuticals | 5.90M |
| Cadrenal Therapeutics | 5.67M |
| BioRestorative Therapies | 5.62M |
| PharmaCyte Biotech | 5.52M |